Navigation Links
Lesotho takes new steps toward HIV/AIDS elimination
Date:2/3/2014

WASHINGTON, D.C.February 3, 2014The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is pleased to announce the expansion of its HIV and AIDS treatment and prevention programs in six districts in Lesotho. With support from the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the additional services offered through EGPAF's Strengthening Clinical Services (SCS) project reflect a programmatic shift that will bolster Lesotho's efforts to eliminate HIV and AIDS.

Based on recommendations from PEPFAR, EGPAF now offers a comprehensive HIV/AIDS care and treatment package in the districts of Mokhotlong, Butha Buthe, Maseru, Mafeteng, Mohale's Hoek, and Thaba in Lesotho.

"Lesotho has lagged behind other countries in sub-Saharan Africa in terms of reducing new HIV infections," said Appolinaire Tiam, country director of EGPAF-Lesotho. "This programmatic shift will allow us to accelerate our efforts to prevent new HIV infections and provide HIV care and treatment to those in need."

The comprehensive package of HIV services provided under the programmatic expansion include improved access to HIV testing and counseling, prevention of mother-to-child transmission (PMTCT) of HIV services, early infant diagnosis of HIV, adult and pediatric HIV care and treatment, nutrition programs, tuberculosis prevention and treatment, and health system strengthening.

EGPAF-supported district mentors and facility-level nurses will work directly with the Lesotho Ministry of Health (MOH) at the district and site level to build capacity and strengthen health systems. District mentors will provide technical assistance and offer supportive supervision to health facilities. The district teams will be supported by a team of program advisors composed of of experts in areas related to the new scope of work. In addition, EGPAF will continue to provide vehicle drivers to address logistics and transportation gaps in the six districts it supports.

Lesotho has the third highest HIV/AIDS prevalence rate in the world, with 23 percent of its population currently living with HIV or AIDS. Since 2004, EGPAF has worked with the Lesotho MOH to provide comprehensive HIV testing, treatment, and prevention services.


'/>"/>

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation
Source:Eurekalert

Related biology news :

1. Are anti-poaching efforts repeating the mistakes of the war on drugs?
2. Algae to crude oil: Million-year natural process takes minutes in the lab
3. Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential
4. Battle against resistant bacteria takes huge leap forward
5. Rats! Humans and rodents process their mistakes
6. ISFM takes a stand on welfare of unowned cats
7. Studies support population-based efforts to lower excessive dietary sodium intakes
8. Zeal to ensure clean leafy greens takes bite out of riverside habitat in California
9. New lung cancer study takes page from Googles playbook
10. Research secured for the future: Pensoft Publishers takes on CLOCKSS archival technology
11. Activating RNA takes DNA on a loop through time and space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... NC (PRWEB) , ... March 27, 2017 , ... ... Clinical Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on ... way they collaborate to drive improved clinical trial outcomes and bring them closer to ...
(Date:3/27/2017)... 2017 Neurotrope, Inc. (OTCQB: NTRP),  a ... diseases, including Alzheimer,s disease, today announced that it ... the Company,s common stock on the NASDAQ Capital ... Market, a unit of the NASDAQ OMX Group. ... Opening Bell at the NASDAQ MarketSite in Times ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
Breaking Biology Technology: